Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis.
Kuan PengJoseph Edgar BlaisNicole L PrattJeff Jianfei GuoJodie B HillenTyman StanfordMichael WardEdward Chia-Cheng LaiJu-Young ShinXinning TongMin FanFranco W T ChengJing WuWinnie W Y YeungChak-Sing LauWai Keung LeungIan C K WongXue LiPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Introduction of the first infliximab biosimilar was not consistently associated with increased consumption across regions. Additional policy and healthcare system interventions to support biosimilar infliximab adoption are needed.